Viral hepatitis is a global burden. In particular, infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) leads to chronic liver disease including fibrosis, cirrhosis and eventually hepatocellular carcinoma (liver cancer) in hundreds of millions of people.1 According to WHO HBV and HCV infections cause approximately 80% of all liver cancer related deaths and kill approximately 1.4 million people every year.2 Most of those infected are undiagnosed, thereby increasing the risk of developing severe liver disease and transmitting the virus to others.
As our knowledge of the diseases evolves, our approach to diagnosing, managing and treating hepatitis patients has evolved alongside. Screening programs require efficient laboratory diagnostic systems to handle large numbers of samples and provide accurate and reliable test results. Personalized treatment strategies – where clinicians rely on accurate diagnostic tests to decide the individual length of treatment– are becoming increasingly important due to the high costs of new antiviral drugs, particularly for hepatitis C. As a result, there are more and more opportunities for collaboration between diagnostic laboratories and clinicians.
Roche Diagnostics brings these key stakeholders together by an integrated and comprehensive offering of cobas® systems and assays that cover the complete hepatitis healthcare continuum - starting with serology-based tests for screening, diagnosis, and prevention3, followed by molecular (PCR-based) tests for e.g. HCV genotyping and viral load monitoring, which play an important role in determining treatment options, duration and predicting treatment response.1
Roche is committed to providing our customers with first-class support and customizable solutions which can be tailored to their specific needs. Our streamlined solutions and services can help laboratories achieve new levels of efficiency and empower clinicians and laboratories to optimize clinical decision-making.
Committed to improving hepatitis disease and patient management
Every diagnostic test – from the initial screening through to viral load testing – can empower viral hepatitis treatment decisions and improve patient outlook. Through collaboration and our streamlined approach, we can help to ensure a smooth progression along the entire workflow, clearing the way for laboratories and clinicians to improve care for hepatitis patients.
Roche offers a broad portfolio of tests required for the screening, diagnosis and management of viral hepatitis. With more than 30 years of experience in the area of Infectious Diseases, Roche covers all relevant diagnostic fields to help provide encompassing patient care, with many major reference and clinical research laboratories using Roche hepatitis products and services.
Not surprisingly, Roche customers regularly leverage our experience as the provider of excellent performing hepatitis immunoassays and extensively clinically validated hepatitis viral load assays worldwide.
From screening to patient management, Roche’s diagnostic excellence and efficiency provides answers today for a healthier tomorrow.
A family of platforms for every throughput need - flexibility to manage your daily workload
Roche has developed the cobas® family of diagnostic platforms (immunochemistry analyzers; molecular analyzers) to provide a common architecture that delivers a tailor-made solution for your laboratory specific workload and testing requirements. As your workload and demands grow, select the right solution that helps you fulfill your requirements.
The cobas® platform family is designed to reduce the complexity of laboratory operations and provide efficient and compatible solutions for network cooperation.
Workflow and IT solutions for streamlined lab operations
Speed of result delivery and cost effectiveness of operations is of the utmost importance in today’s healthcare systems.
cobas® infinity and middleware solutions go beyond laboratory workflow management. They provide an efficient workflow of patient data information and streamline laboratory service across various clinical disciplines.
These solutions contribute to our vision of delivering an optimized laboratory that enables our customers to surpass today’s limitations and gain more control and flexibility in daily operations while improving the overall value of care.
Your lab operations - backed up with the excellence of Roche service and support
Consistency – Our field service and technical support processes have been globally standardized and proven to provide results efficiently and consistently.
Expertise – Technical support hotlines provide immediate access to local support teams which consist of experienced engineers backed by global experts providing assistance to help you with any queries and problems.
Efficiency – Through Roche training, your technical staff will acquire new skills designed to maximize the value of your state-of-the-art systems – decreasing down-time, reducing support request, and increasing productivity.
Confidence – Roche provides guidance on best-in-class validation practices for you to further qualify your system’s operation and performance in your lab.
Rapid solutions – Superior on-site technical support - when you need it, where you need it. Our service specialists have access to local and global support centers to ensure rapid solutions for your lab.
Efficient troubleshooting – Roche service and support staff can help you solve your problems efficiently with immediate online access to a globally standardized database containing the latest product updates and information essential for efficient troubleshooting.
Commitment – Your calls are logged and monitored in a centralized complaint management system for monitoring and closure with appropriate action.
Available for you – The backbone of our service and support network consists of more than 2,000 field and technical experts serving Roche Diagnostic customers in more than 140 countries.
- Mauss S et al. Hepatology – A Clinical Textbook; 7th Edition, 2016. Medizin Fokus Verlag
- http://www.who.int/mediacentre/news/releases/2015/world-hepatitis-day/en/post-vaccination testing